Emerging roles for endocannabinoids in long-term synaptic plasticity

British Journal of Pharmacology

Volumn 140, Issue 5, 2003, Pages 781-789

  Gerdeman, Gregory L ^a   Lovinger, David M ^b  

^a UNIVERSITY OF ARIZONA   (United States)

^b NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

Author keywords

Cannabinoids; CB1 receptor; Hippocampus; Long term depression; Long term potentiation; Nucleus accumbens; Retrograde messenger; Striatum

Indexed keywords

2 ARACHIDONOYLGLYCEROL; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; ANANDAMIDE; CALCIUM CHELATING AGENT; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CANNABINOID DERIVATIVE; CANNABINOID RECEPTOR AFFECTING AGENT; CANNABINOID RECEPTOR AGONIST; CANNABINOID RECEPTOR ANTAGONIST; CANNABINOID REUPTAKE INHIBITOR; DRONABINOL; FATTY ACID AMIDASE; G PROTEIN COUPLED RECEPTOR; GLUTAMATE RECEPTOR AGONIST; METABOTROPIC RECEPTOR; N (4 HYDROXYPHENYL)ARACHIDONAMIDE; PARTIAL AGONIST; PHOSPHATIDYLETHANOLAMINE; RIMONABANT; UNCLASSIFIED DRUG; VIRODHAMINE;

BINDING SITE; BRAIN REGION; CALCIUM SIGNALING; CEREBELLUM; DEPOLARIZATION; ENZYME INHIBITION; GABAERGIC SYSTEM; HIPPOCAMPUS; HUMAN; LONG TERM POTENTIATION; NERVE CELL PLASTICITY; NEUROTRANSMITTER RELEASE; PREFRONTAL CORTEX; PRESYNAPTIC INHIBITION; PRESYNAPTIC NERVE; PRIORITY JOURNAL; RECEPTOR BINDING; SHORT SURVEY; SPIKE WAVE; SYNAPTIC INHIBITION; SYNAPTIC TRANSMISSION; VISUAL CORTEX;

ANIMALS; BRAIN; ENDOCANNABINOIDS; HUMANS; NEURONAL PLASTICITY; RECEPTORS, CANNABINOID; SYNAPSES; TIME;

EID: 0344441319     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0705466     Document Type: Short Survey

References (78)

1. ALGER, B. (2002). Retrograde signaling in the regulation of synaptic transmission: focus on endocannabinoids. Prog. Neurobiol., 68, 247-286.
2. AUCLAIR, N., OTANI, S., SOUBRIE, P. & CREPEL, F. (2000). Cannabinoids modulate synaptic strength and plasticity at glutamatergic synapses of rat prefrontal cortex pyramidal neurons. J. Neurophysiol., 83, 3287-3293.
3. AZAD, S.C., EDER, M., MARSICANO, G., LUTZ, B., ZIEGLGANSBERGER, W. & RAMMES, G. (2003). Activation of the cannabinoid receptor type 1 decreases glutamatergic and GABAergic synaptic transmission in the lateral amygdala of the mouse. Learn Mem., 10, 116-128.
4. BARBARA, J.G., AUCLAIR, N., ROISIN, M.P., OTANI, S., VALJENT, E., CABOCHE, J., SOUBRIE, P. & CREPEL, F. (2003). Direct and indirect interactions between cannabinoid CB1 receptor and group II metabotropic glutamate receptor signalling in layer V pyramidal neurons from the rat prefrontal cortex. Eur. J. Neurosci., 17, 981-990.
5. BARNES, C.A. & MCNAUGHTON, B.L. (1985). An age comparison of the rates of acquisition and forgetting of spatial information in relation to long-term enhancement of hippocampal synapses. Behav. Neurosci., 99, 1040-1048.
6. BERKE, J.D. & HYMAN, S.E. (2000). Addiction, dopamine, and the molecular mechanisms of memory. Neuron, 25, 515-532.
7. BOHME, G.A., LAVILLE, M., LEDENT, C., PARMENTIER, M. & IMPERATO, A. (2000). Enhanced long-term potentiation in mice lacking cannabinoid CB1 receptors. Neuroscience, 95, 5-7.
8. BREIVOGEL, C.S., CHILDERS, S.R., DEADWYLER, S.A., HAMPSON, R.E., VOGT, L.J. & SIM-SELLEY, L.J. (1999). Chronic delta9-tetrahydrocannabinol treatment produces a time-dependent loss of cannabinoid receptors and cannabinoid receptor-activated G proteins in rat brain. J. Neurochem., 73, 2447-2459.
9. CALABRESI, P., MAJ, R., PISANI, A., MERCURI, N.B. & BERNARDI, G. (1992). Long-term synaptic depression in the striatum: physiological and pharmacological characterization. J. Neurosci., 12, 4224-4233.
10. CARLSON, G., WANG, Y. & ALGER, B.E. (2002). Endocannabinoids facilitate the induction of LTP in the hippocampus. Nat. Neurosci., 5, 723-724.
11. CHEMIN, J., MONTEIL, A., PEREZ-REYES, E., NARGEOT, J. & LORY, P. (2001). Direct inhibition of T-type calcium channels by the endogenous cannabinoid anandamide. EMBO J., 20, 7033-7040.
12. CHEVALEYRE, V. & CASTILLO, P.E. (2003). Heterosynaptic LTD of hippocampal GABAergic synapses: a novel role of endocannabinoids in regulating excitability. Neuron, 38, 461-472.
13. CHOI, S. & LOVINGER, D.M. (1997a). Decreased frequency but not amplitude of quantal synaptic responses associated with expression of corticostriatal long-term depression. J. Neurosci., 17, 8613-8620.
14. CHOI, S. & LOVINGER, D.M. (1997b). Decreased probability of neurotransmitter release underlies striatal long-term depression and postnatal development of corticostriatal synapses. Proc. Natl. Acad. Sci. U.S.A., 94, 2665-2670.
15. CLEMENTS, J. (1993). Presynaptic receptors and quantal models of synaptic transmission. In: Presynaptic Receptors in the Mammalian Brain. eds. Dunwiddie, T.V. & Lovinger, D.M. pp. 180-196. Boston: Birkhäuser Inc.
16. DAVIES, C.H., STARKEY, S.J., POZZA, M.F. & COLLINGRIDGE, G.L. (1991). GABA autoreceptors regulate the induction of LTP. Nature, 349, 609-611.
17. DEL ARCO, I., NAVARRO, M., BILBAO, A., FERRER, B., PIOMELLI, D. & RODRIGUEZ DE FONSECA, F. (2002). Attenuation of spontaneous opiate withdrawal in mice by the anandamide transport inhibitor AM404. Eur. J. Pharmacol., 454, 103-104.
18. DEUTSCH, D.G., GLASER, S.T., HOWELL, J.M., KUNZ, J.S., PUFFENBARGER, R.A., HILLARD, C.J. & ABUMRAD, N. (2001). The cellular uptake of anandamide is coupled to its breakdown by fatty-acid amide hydrolase. J. Biol. Chem., 276, 6967-6973.
19. DI MARZO, V., DE PETROCELLIS, L., FEZZA, F., LIGRESTI, A. & BISOGNO, T. (2002). Anandamide receptors. Prostaglandins Leukot. Essent. Fatty Acids, 66, 377-391.
20. DI MARZO, V., FONTANA, A., CADAS, H., SCHINELLI, S., CIMINO, G., SCHWARTZ, J.C. & PIOMELLI, D. (1994). Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature, 372, 686-691.
21. DINH, T.P., CARPENTER, D., LESLIE, F.M., FREUND, T.F., KATONA, I., SENSI, S.L., KATHURIA, S. & PIOMELLI, D. (2002). Brain monoglyceride lipase participating in endocannabinoid inactivation. Proc. Natl. Acad. Sci. U.S.A., 99, 10819-10824.
22. DOHERTY, J. & DINGLEDINE, R. (2003). Functional interactions between cannabinoid and metabotropic glutamate receptors in the central nervous system. Curr. Opin. Pharmacol., 3, 46-53.
23. EGERTOVA, M., GIANG, D.K., CRAVATT, B.F. & ELPHICK, M.R. (1998). A new perspective on cannabinoid signalling: complementary localization of fatty acid amide hydrolase and the CB1 receptor in rat brain. Proc. R. Soc. Lond. Ser., 265, 2081-2085.
24. FREUND, T.F., KATONA, I. & PIOMELLI, D. (2003). Role of endogenous cannabinoids in synaptic signaling. Physiol. Rev., 83, 1017-1066.
25. FRIED, P., WATKINSON, B., JAMES, D. & GRAY, R. (2002). Current and former marijuana use: preliminary findings of a longitudinal study of effects on IQ in young adults. CMAJ, 166, 887-891.
26. GERDEMAN, G. & LOVINGER, D.M. (2001). CB1 cannabinoid receptor inhibits synaptic release of glutamate in rat dorsolateral striatum. J. Neurophysiol., 85, 468-471.
27. GERDEMAN, G.L., PARTRIDGE, J.G., LUPICA, C.R. & LOVINGER, D.M. (2003). It could be habit forming: drugs of abuse and striatal synaptic plasticity. Trends Neurosci., 26, 184-192.
28. GERDEMAN, G.L., RONESI, J. & LOVINGER, D.M. (2002a). Post-synaptic endocannabinoid release is critical to long-term depression in the striatum. Nat. Neurosci., 5, 451-466.
29. GERDEMAN, G.L., RONESI, J. & LOVINGER, D.M. (2002b). Striatal long term depression depends on efflux of retrograde endocannabinoids via reverse transport. In: Program No . 648.13. 2002 Abstract Viewer/Itinerary Planner. Washington, DC: Society for Neuroscience, CD-ROM.
30. GIUFFRIDA, A., PARSONS, L.H., KERR, T.M., RODRIGUEZ DE FONSECA, F., NAVARRO, M. & PIOMELLI, D. (1999). Dopamine activation of endogenous cannabinoid signaling in dorsal striatum. Nat. Neurosci., 2, 358-363.
31. GLASER, S.T., ABUMRAD, N.A., FATADE, F., KACZOCHA, M., STUDHOLME, K.M. & DEUTSCH, D.G. (2003). Evidence against the presence of an anandamide transporter. Proc. Natl. Acad. Sci. U.S.A., 100, 4269-4274.
32. GLASS, M. & FELDER, C.C. (1997). Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: evidence for a Gs linkage to the CB1 receptor. J. Neurosci., 17, 5327-5333.
33. GUBELLINI, P., SAULLE, E., CENTONZE, D., BONSI, P., PISANI, A., BERNARDI, G., CONQUET, F. & CALABRESI, P. (2001). Selective involvement of mGlu1 receptors in corticostriatal LTD. Neuropharmacohgy, 40, 839-846.
34. HAJOS, N. & FREUND, T.F. (2002). Distinct cannabinoid sensitive receptors regulate hippocampal excitation and inhibition. Chem. Phys. Lipids, 121, 73-82.
35. HAMPSON, R.E. & DEADWYLER, S.A. (1999). Cannabinoids, hippocampal function and memory. Life Sci., 65, 715-723.
36. HAMPSON, R.E., ZHUANG, S.Y., WEINER, J.L. & DEADWYLER, S.A. (2003). Functional significance of cannabinoid-mediated, depolarization induced suppression of inhibition (DSI) in the hippocampus. J. Neurophysiol., 90, 55-64.
37. HILLARD, C.J. & JARRAHIAN, A. (2000). The movement of N-arachidonoylethanolamine (anandamide) across cellular membranes. Chem. Phys. Lipids, 108, 123-134.
38. HOFFMAN, A.F., OZ, M., CAULDER, T. & LUPICA, C.R. (2003). Functional tolerance and blockade of long-term depression at synapses in the nucleus accumbens following chronic cannabinoid exposure. J. Neurosci., 23, 4815-4820.
39. HOWLETT, A.C., BARTH, F., BONNER, T.I., CABRAL, G., CASELLAS, P., DEVANE, W.A., FELDER, C.C., HERKENHAM, M., MACKIE, K., MARTIN, B.R., MECHOULAM, R. & PERTWEE, R.G. (2002). International Union of Pharmacology XXVII. classification of cannabinoid receptors. Pharmacol. Rev., 54, 161-202.
40. HUANG, C.C., LO, S.W. & HSU, K.S. (2001). Presynaptic mechanisms underlying cannabinoid inhibition of excitatory synaptic transmission in rat striatal neurons. J. Physiol., 532, 731-748.
41. HUNGUND, B.L., BASAVARAJAPPA, B.S., VADASZ, C., KUNOS, G., RODRIGUEZ DE FONSECA, F., COLOMBO, G., SERRA, S., PARSONS, L. & KOOB, G.F. (2002). Ethanol, endocannabinoids, and the cannabinoidergic signaling system. Alcohol Clin. Exp. Res., 26, 565-574.
42. KATONA, I., RANCZ, E.A., ACSADY, L., LEDENT, C., MACKIE, K., HAJOS, N. & FREUND, T.F. (2001). Distribution of CB1 cannabinoid receptors in the amygdala and their role in the control of GABAergic transmission. J. Neurosci., 21, 9506-9518.
43. KEMP, N. & BASHIR, Z.I. (2001). Long-term depression: a cascade of induction and expression mechanisms. Prog. Neurobiol., 65, 339-365.
44. KIM, D. & THAYER, S.A. (2001). Cannabinoids inhibit the formation of new synapses between hippocampal neurons in culture. J. Neurosci., 21, RC146.
45. KIM, J., ISOKAWA, M., LEDENT, C. & ALGER, B.E. (2002). Activation of muscarinic acetylcholine receptors enhances the release of endogenous cannabinoids in the hippocampus. J. Neurosci., 22, 10182-10191.
46. KREITZER, A.C. & REGEHR, W.G. (2001). Retrograde inhibition of presynaptic calcium influx by endogenous cannabinoids at excitatory synapses onto Purkinje cells. Neuron, 29, 717-727.
47. LEVENES, C., DANIEL, H., SOUBRIE, P. & CREPEL, F. (1998). Cannabinoids decrease excitatory synaptic transmission and impair long-term depression in rat cerebellar Purkinje cells. J. Physiol., 510, 867-879.
48. LLANO, I., LERESHCE, N. & MARTY, A. (1991). Calcium entry increases the sensitivity of cerebellar Purkinje cells to applied GABA and decreases inhibitory synaptic currents. Neuron, 6, 565-574.
49. MAEJIMA, T., HASHIMOTO, K., YOSHIDA, T., AIBA, A. & KANO, M. (2001). Presynaptic inhibition caused by retrograde signal from metabotropic glutamate to cannabinoid receptors. Neuron, 31, 463-475.
50. MAINGRET, F., PATEL, A.J., LAZDUNSKI, M. & HONORE, E. (2001). The endocannabinoid anandamide is a direct and selective blocker of the background K(+) channel TASK-1. EMBO J., 20, 47-54.
51. MALDONADO, R. & RODRIGUEZ DE FONSECA, F. (2002). Cannabinoid addiction: behavioral models and neural correlates. J. Neurosci., 22, 3326-3331.
52. MALINOW, R., MAINEN, Z.F. & HAYASHI, Y. (2000). LTP mechanisms: from silence to four-lane traffic. Curr. Opin. Neurobiol., 10, 352-357.
53. MARINELLI, S., DI MARZO, V., BERRETTA, N., MATIAS, I., MACCARRONE, M., BERNARDI, G. & MERCURI, N.B. (2003). Presynaptic facilitation of glutamatergic synapses to dopaminergic neurons of the rat substantia nigra by endogenous stimulation of vanilloid receptors. J. Neurosci., 23, 3136-3144.
54. MARSICANO, G., WOTJAK, C.T., AZAD, S.C., BISOGNO, T., RAMMES, G., CASCIO, M.G., HERMANN, H., TANG, J., HOFMANN, C., ZIEGLGANSBERGER, W., DI MARZO, V. & LUTZ, B. (2002). The endogenous cannabinoid system controls extinction of aversive memories. Nature, 418, 530-534.
55. MARTIN, S.J., GRIMWOOD, P.O. & MORRIS, R.G. (2000). Synaptic plasticity and memory: an evaluation of the hypothesis. Annu. Rev. Neurosci., 23, 649-711.
56. MECHOULAM, R. (2002). Discovery of endocannabinoids and some random thoughts on their possible roles in neuroprotection and aggression. Prostaglandins Leukot. Essent. Fatty Acids, 66, 93-99.
57. MISNER, D.L. & SULLIVAN, J.M. (1999). Mechanism of cannabinoid effects on long-term potentiation and depression in hippocampal CA1 neurons. J. Neurosci., 19, 6795-6805.
58. NICOLL, R.A. & MALENKA, R.C. (1999). Expression mechanisms underlying NMDA receptor-dependent long-term potentiation. Ann. NY Acad. Sci., 868, 515-525.
59. OHNO-SHOSAKU, T., TSUBOKAWA, H., MIZUSHIMA, I., YONEDA, N., ZIMMER, A. & KANO, M. (2002). Presynaptic cannabinoid sensitivity is a major determinant of depolarization-induced retrograde suppression at hippocampal synapses. J. Neurosci., 22, 3864-3872.
60. PIOMELLI, D., BELTRAMO, M., GLASNAPP, S., LIN, S.Y., GOUTOPOULOS, A., XIE, X.Q. & MAKRIYANNIS, A. (1999). Structural determinants for recognition and translocation by the anandamide transporter. Proc. Natl. Acad. Sci. U.S.A., 96, 5802-5807.
61. PITLER, T.A. & ALGER, B.E. (1994). Depolarization-induced suppression of GABAergic inhibition in rat hippocampal pyramidal cells: G protein involvement in a presynaptic mechanism. Neuron, 13, 1447-1455.
62. PORTER, A.C., SAUER, J.M., KNIERMAN, M.D., BECKER, G.W., BERNA, M.J., BAO, J., NOMIKOS, G.G., CARTER, P., BYMASTER, F.P., LEESE, A.B. & FELDER, C.C. (2002). Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor. J. Pharmacol. Exp. Ther., 301, 1020-1024.
63. REIBAUD, M., OBINU, M.C., LEDENT, C., PARMENTIER, M., BOHME, G.A. & IMPERATO, A. (1999). Enhancement of memory in cannabinoid CB1 receptor knock-out mice. Eur. J. Pharmacol., 379, R1-R2.
64. ROBBE, D., KOPF, M., REMAURY, A., BOCKAERT, J. & MANZONI, O.J. (2002). Endogenous cannabinoids mediate long-term synaptic depression in the nucleus accumbens. Proc. Natl. Acad. Sci. U.S.A., 99, 8384-8388.
65. SCHLICKER, E. & KATHMANN, M. (2001). Modulation of transmitter release via presynaptic cannabinoid receptors. Trends Pharmacol. Sci., 22, 565-572.
66. SILVA, A.J. (2003). Molecular and cellular cognitive studies of the role of synaptic plasticity in memory. J. Neurobiol., 54, 224-237.
67. SJOSTROM, P.J. & NELSON, S.B. (2002). Spike timing, calcium signals and synaptic plasticity. Curr. Opin. Neurobiol., 12, 305-314.
68. SJOSTROM, P.J., TURRIGIANO, G.G. & NELSON, S.B. (2003). Neocortical LTD via coincident activation of presynaptic NMDA and cannabinoid receptors. Neuron, 39, 1-20.
69. SUNG, K.W., CHOI, S. & LOVINGER, D.M. (2001). Activation of group I mGluRs is necessary for induction of long-term depression at striatal synapses. J. Neurophysiol., 86, 2405-2412.
70. TANG, K., LOW, M.J., GRANDY, D.K. & LOVINGER, D.M. (2001). Dopamine-dependent synaptic plasticity in striatum during in vivo development. Proc. Natl. Acad. Sci. U.S.A., 98, 1255-1260.
71. TAO, H.W. & POO, M. (2001). Retrograde signaling at central synapses. Proc. Natl. Acad. Sci. U.S.A., 98, 11009-11015.
72. VARMA, N., CARLSON, G.C., LEDENT, C. & ALGER, B.E. (2001). Metabotropic glutamate receptors drive the endocannabinoid system in hippocampus. J. Neurosci., 21, RC188.
73. VASQUEZ, C. & LEWIS, D.L. (1999). The CB1 cannabinoid receptor can sequester G-proteins, making them unavailable to couple to other receptors. J. Neurosci., 19, 9271-9280.
74. VELA, G., RUIZ-GAYO, M. & FUENTES, J.A. (1995). Anandamide decreases naloxone-precipitated withdrawal signs in mice chronically treated with morphine. Neuropharmacology, 34, 665-668.
75. WANG, L., LIU, J., HARVEY-WHITE, J., ZIMMER, A. & KUNOS, G. (2003). Endocannabinoid signaling via cannabinoid receptor 1 is involved in ethanol preference and its age-dependent decline in mice. Proc. Natl. Acad. Sci. U.S.A., 100, 1393-1398.
76. WILLIAMS, E.J., WALSH, F.S. & DOHERTY, P. (2003). The FGF receptor uses the endocannabinoid signaling system to couple to an axonal growth response. J. Cell. Biol., 160, 481-486.
77. WILSON, R.I. & NICOLL, R.A. (2002). Endocannabinoid signaling in the brain. Science, 296, 678-682.
78. YAMAGUCHI, T., HAGIWARA, Y., TANAKA, H., SUGIURA, T., WAKU, K., SHOYAMA, Y., WATANABE, S. & YAMAMOTO, T. (2001). Endogenous cannabinoid, 2-arachidonoylglycerol, attenuates naloxone-precipitated withdrawal signs in morphine-dependent mice. Brain Res., 909, 121-126.